Are pharma teams ready for the next customer engagement mode...
The infrastructure is largely in place.
Newsletters and Deep Dive digital magazine
The infrastructure is largely in place.
Multiple sclerosis (MS) is undergoing a meaningful evolution in how it is understood, diagnosed, and managed.
Clinical trials struggle in many areas, and significantly in recruitment.
The tools, the methodologies, and the AI capabilities to drive MedTech transformation exist today.
A closer look at how controlled crystallisation and complementary approaches can be used to efficiently separate and purify chiral molecules.
Editor's Picks
Newsletters and Deep Dive
digital magazine